ioSkeletal Myocytes

Human-Induced Skeletal Myocytes

EA1200  |  Early Access Product

Introducing highly-defined, consistent and reliable human muscle cells for research, disease modelling and high throughput screening across areas such as muscle, neuromuscular, and associated metabolic disorders. ioSkeletal Myocytes have been reprogrammed from human induced pluripotent stem cells (iPSCs) using our precise reprogramming technology: opti-ox¹.

The technology allows for human pluripotent stem cells, within days, to convert into skeletal myocytes, providing a high-quality, easy to use, cellular model.

Skeletal myocytes demonstrate robust expression of components of the contractile apparatus and form striated, multinucleated, myocytes by Day 10 post revival, that contract in response to acetylcholine.

Unprecedented batch-to-batch consistency allows for their use in demanding screening applications where small changes need to be detected against background noise.

¹ Pawlowski et al., Stem Cell Report 2017

Advantages:

Ready for experimentation within days
Highly characterised and defined
Easy culturing


Applications:

– Muscle, neuromuscular and metabolic research
– Amenable to high throughput screening
– Contractility assays
– 3D cocultures
– Genetic screening (e.g. CRISPR screening)

For more information please email:
info@bit.bio

consistency

Batch to batch reproducibility and homogeneity create a stable human model the study of muscle, neuromuscular, and associated metabolic disorders.

speed

Form striated, multinucleated, myocytes by Day 10 post revival, that contract in response to acetylcholine.

scalability

Industrial scale quantities at a price point that allows the cells to be used from research to screening scale.

ease of use

Cells arrive programmed to rapidly mature upon revival. One medium required in a two-step protocol.

ioSkeletal Myocytes generated by MYOD1-driven reprogramming of iPSCs using opti-ox technology

Video capturing the rapid morphological changes from iPSCs upon induction of MYOD1 expression using opti-ox cellular reprogramming. 10 day time course.

ioSkeletal Myocytes express skeletal myocyte-specific markers

Immunofluorescence staining at day 10 post revival demonstrates robust expression of components of the contractile apparatus such as Desmin (A), Dystrophin (B), and Myosin Heavy Chain (C), along with the muscle transcription factor Myogenin (C). Cells also demonstrate expression of Troponin with visible striated fibres and multinucleation (D).

Cells demonstrate classical myocyte morphology

Day 3
day 5
day 10

ioSkeletal Myocytes form elongated multinucleated myocytes over 10 days. Day 1 to 10 post-thawing; 4X magnification; scale bar: 800µm

Cells demonstrate gene expression of key myogenic markers following reprogramming

myocyte gene expression C447

Following reprogramming, ioSkeletal Myocytes downregulate expression of the pluripotency genes (A), whilst demonstrating robust expression of key myogenic markers (B). Gene expression levels assessed by RT-qPCR (data expressed relative to the parental hiPSC, normalised to HMBS). Data represents Day 10 post-revival samples; n=7 biological replicates.

Cells express the insulin regulated glucose transporter GLUT4, critical for metabolic studies

Figure 5 GLUT4
Figure 5 GLUT4

(A) RT-qPCR, at Day 10 post-revival, demonstrating expression of GLUT4 in the ioSkeletal Myocytes, compared to undifferentiated hiPSCs and ioGlutamatergic Neurons (formerly known as ioNEURONS/glut). (B) Immunocytochemistry, at Day 7 post-revival, demonstrates expression of GLUT4 in peri-nuclear regions, and striations, in the ioSkeletal Myocytes*. (C) Western blotting of differentiated 3T3-L1 adipocytes and maturing ioSkeletal Myocytes demonstrates GLUT4 expression in a time-dependent manner*.

* Dougall Norris & Daniel Fazakerley, Wellcome-MRC Institute of Metabolic Science

In vitro human muscle cells suitable for contractility assays

By Day 10 post-revival, cells demonstrate a strong contractile response upon addition of acetylcholine, providing a suitable human muscle model for contractility assays. Spontaneous contraction is also observed during continuous culture (data not shown). Day 10 post-revival skeletal myocytes; 50µM acetylcholine.

Cells arrive ready to plate

vials of myocyte cells
Figure 7 Myocyte cells arrive ready to plate

ioSkeletal Myocytes are delivered in a cryopreserved format and are programmed to rapidly mature upon revival in the recommended medium. The protocol for the generation of these cells is a three-phase process: 1. Induction (carried out at bit.bio) 2. Stabilization for 3 days with Dox 3. Maintenance during which the skeletal myocytes mature.

Available in two vial sizes, tailored to suit your experimental needs with minimal waste

myocytes plating sizes

Recommended seeding density for ioSkeletal Myocytes is 100,000 cells/cm2. One Small vial can plate a minimum of 0.5 x 24-well plate, 0.75 x 96-well plate, or 1 x 384-well plate. One Large vial can plate a minimum of 1 x 24-well plate, 1.5 x 96-well plate, or 2 x 384-well plates.

Product Information


Catalogue number: EA1200 Manufacture site: United Kingdom Sizes: Small & Large Product use: These cells are for research use only Storage: Upon receiving, directly and immediately transfer the cells from dry ice to liquid nitrogen and keep the cells in liquid nitrogen until they are needed for experiments Shipping info: Dry Ice Note: Limited Use License | Statement of Use